{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T04:22:34Z","timestamp":1787026954662,"version":"build-2736575974"},"reference-count":24,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,5,27]],"date-time":"2025-05-27T00:00:00Z","timestamp":1748304000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Nutr."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Non-alcoholic fatty liver disease (NAFLD) is a prevalent chronic liver disorder characterized by excessive hepatic fat accumulation without significant alcohol consumption. While obesity is a major risk factor, many non-obese individuals also develop NAFLD. However, research on this subgroup remains limited, and its underlying risk factors are unclear. Nutritional status plays a key role in NAFLD pathogenesis. The geriatric nutritional risk index (GNRI), widely used to assess nutrition, is linked to adverse health outcomes. However, its association with NAFLD in non-obese individuals remains poorly understood.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      A\n                      <jats:italic>post-hoc<\/jats:italic>\n                      evaluation was conducted using longitudinal data from the Dryad repository, derived from health screenings of non-obese individuals at Wenzhou People\u2019s Hospital (2010\u20132014). Participants with baseline NAFLD, alcohol abuse, metabolic disorders, or liver diseases were excluded. The Geriatric Nutritional Risk Index (GNRI) was calculated using serum albumin and weight-to-ideal weight ratios (Lorentz equations). Eligible participants were categorized into quartiles based on GNRI values. NAFLD was diagnosed via ultrasound following Chinese Liver Disease Association criteria. Cox proportional hazards regression (adjusted for confounders in three models), Kaplan\u2013Meier analysis, and restricted cubic splines were employed to evaluate associations between GNRI and NAFLD incidence. Linear trends and subgroup interactions were tested. Statistical analyses were performed using R (v4.0).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>The participants in higher GNRI groups had a higher risk of developing NAFLD, even after adjusting for confounding factors. This association was consistent across different body mass index (BMI) levels, although the trend was less significant in the higher BMI group. Furthermore, subgroup analysis revealed a consistent association between GNRI and NAFLD incidence in different sex, age, BMI, and systolic blood pressure (SBP) groups. However, there were some interactions observed in different alanine aminotransferase (ALT) groups.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Our findings suggest that GNRI may serve as a useful indicator for predicting the risk of NAFLD in non-obese individuals, providing valuable insights for early detection and intervention strategies for this condition.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fnut.2025.1574070","type":"journal-article","created":{"date-parts":[[2025,5,27]],"date-time":"2025-05-27T00:11:04Z","timestamp":1748304664000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":7,"title":["Association between GNRI and risk of non-alcoholic fatty liver disease in non-obese individuals: a Chinese longitudinal prospective cohort study"],"prefix":"10.3389","volume":"12","author":[{"given":"Linlin","family":"Shen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siyu","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haoran","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiyan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiashu","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ke","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,5,27]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"1999","DOI":"10.1053\/j.gastro.2019.11.312","article-title":"MAFLD: a consensus-driven proposed nomenclature for metabolic associated fatty liver disease","volume":"158","author":"Eslam","year":"2020","journal-title":"Gastroenterology"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"2212","DOI":"10.1016\/S0140-6736(20)32511-3","article-title":"Non-alcoholic fatty liver disease","volume":"397","author":"Powell","year":"2021","journal-title":"Lancet"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"12","DOI":"10.3390\/biom12060824","article-title":"NAFLD: mechanisms, treatments, and biomarkers","volume":"12","author":"Nassir","year":"2022","journal-title":"Biomol Ther"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"1605","DOI":"10.1002\/hep.31173","article-title":"Changes in the global burden of chronic liver diseases from 2012 to 2017: the growing impact of NAFLD","volume":"72","author":"Paik","year":"2020","journal-title":"Hepatology"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"1691","DOI":"10.1136\/gutjnl-2020-320622","article-title":"NAFLD and increased risk of cardiovascular disease: clinical associations, pathophysiological mechanisms and pharmacological implications","volume":"69","author":"Targher","year":"2020","journal-title":"Gut"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2020\/3920196","article-title":"The intricate relationship between type 2 diabetes mellitus (T2DM), insulin resistance (IR), and nonalcoholic fatty liver disease (NAFLD)","volume":"2020","author":"Tanase","year":"2020","journal-title":"J Diabetes Res"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"154433","DOI":"10.1016\/j.metabol.2020.154433","article-title":"MAFLD and risk of CKD","volume":"115","author":"Sun","year":"2021","journal-title":"Metabolism"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1210\/clinem\/dgab641","article-title":"Association of MAFLD with diabetes, chronic kidney disease, and cardiovascular disease: a 4.6-year cohort study in China","volume":"107","author":"Liang","year":"2022","journal-title":"J Clin Endocrinol Metab"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1016\/S2468-1253(20)30077-7","article-title":"Global prevalence, incidence, and outcomes of non-obese or lean non-alcoholic fatty liver disease: a systematic review and meta-analysis","volume":"5","author":"Ye","year":"2020","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1093\/ajcn\/82.4.777","article-title":"Geriatric nutritional risk index: a new index for evaluating at-risk elderly medical patients","volume":"82","author":"Bouillanne","year":"2005","journal-title":"Am J Clin Nutr"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"1477","DOI":"10.1007\/s40520-020-01656-3","article-title":"Prognostic value of geriatric nutritional risk index in elderly patients with heart failure: a meta-analysis","volume":"33","author":"Li","year":"2021","journal-title":"Aging Clin Exp Res"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"211","DOI":"10.20407\/fmj.2022-028","article-title":"Geriatric nutritional risk index as readmission predictor in older adults with heart failure irrespective of ejection fraction","volume":"9","author":"Sato","year":"2023","journal-title":"Fujita Med J"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"15","DOI":"10.3390\/nu15173831","article-title":"The geriatric nutritional risk index is an optimal evaluation parameter for predicting mortality in adult all ages hemodialysis patients: a Korean population-based study","volume":"15","author":"Kim","year":"2023","journal-title":"Nutrients"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"e13781","DOI":"10.1136\/bmjopen-2016-013781","article-title":"Association of low-density lipoprotein cholesterol within the normal range and NAFLD in the non-obese Chinese population: a cross-sectional and longitudinal study","volume":"6","author":"Sun","year":"2016","journal-title":"BMJ Open"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"1522","DOI":"10.1016\/j.clnu.2016.04.010","article-title":"Geriatric nutritional risk index, muscle function, quality of life and clinical outcome in hemodialysis patients","volume":"35","author":"Beberashvili","year":"2016","journal-title":"Clin Nutr"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1111\/j.1751-2980.2008.00331.x","article-title":"Guidelines for the diagnosis and treatment of nonalcoholic fatty liver diseases","volume":"9","author":"Zeng","year":"2008","journal-title":"J Dig Dis"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2022\/8793659","article-title":"Risk factors and prediction models for nonalcoholic fatty liver disease based on random Forest","volume":"2022","author":"Li","year":"2022","journal-title":"Comput Math Methods Med"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/j.clnesp.2024.06.015","article-title":"Prevalence and related assessment practices of adult hospital malnutrition in Africa: a scoping review","volume":"63","author":"Visser","year":"2024","journal-title":"Clin Nutr ESPEN"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1186\/s12876-020-1165-z","article-title":"Proportion of NAFLD patients with normal ALT value in overall NAFLD patients: a systematic review and meta-analysis","volume":"20","author":"Ma","year":"2020","journal-title":"BMC Gastroenterol"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"813","DOI":"10.4254\/wjh.v15.i6.813","article-title":"Lower alanine aminotransferase levels are associated with increased all-cause and cardiovascular mortality in nonalcoholic fatty liver patients","volume":"15","author":"Zheng","year":"2023","journal-title":"World J Hepatol"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"5262","DOI":"10.3390\/nu14245262","article-title":"Dietary fat intake among Chinese adults and their relationships with blood lipids: findings from China nutrition and health surveillance and comparison with the PURE study","volume":"14","author":"Zhao","year":"2022","journal-title":"Nutrients"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"1963","DOI":"10.2147\/DMSO.S308387","article-title":"The association between Sarcopenic obesity and hypertension, diabetes, and abnormal lipid metabolism in Chinese adults","volume":"14","author":"Li","year":"2021","journal-title":"Diabetes Metab Syndr Obes"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"17562848251331315","DOI":"10.1177\/17562848251331315","article-title":"A comprehensive analysis of the impact of smoking on adverse clinical outcomes of steatotic liver diseases","volume":"18","author":"Yang","year":"2025","journal-title":"Ther Adv Gastroenterol"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1186\/s12937-025-01128-2","article-title":"Efficacy of structured exercise and oat supplementation for treating non-alcoholic fatty liver disease: protocol of a randomized controlled trial","volume":"24","author":"Yin","year":"2025","journal-title":"Nutr J"}],"container-title":["Frontiers in Nutrition"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fnut.2025.1574070\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,27]],"date-time":"2025-05-27T00:11:05Z","timestamp":1748304665000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fnut.2025.1574070\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,27]]},"references-count":24,"alternative-id":["10.3389\/fnut.2025.1574070"],"URL":"https:\/\/doi.org\/10.3389\/fnut.2025.1574070","relation":{},"ISSN":["2296-861X"],"issn-type":[{"value":"2296-861X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,27]]},"article-number":"1574070"}}